Company profile SRZN

Surrozen Inc
surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the wnt signaling pathway. surrozen is founded by four leading edge scientists from stanford university: k. christopher garcia, ph.d.; roel nusse, ph.d.; calvin kuo, m.d., ph....d.; and claudia janda, ph.d. each has conducted extensive research on wnt signaling, with findings that together shape surrozen’s technology and approach to therapeutic development. the company is backed by the column group, a leading biotechnology venture capital firm. we are currently seeking highly creative scientists to join our founding team, and invite you to explore career opportunities on our website. if you don’t find a perfect job match, but think surrozen may be the right place for you, please submit your resume to careers@surrozen.com. Show More
Quarter analysis & expected interestLast update: February 07 2024 21:32:19.

After 38 days of this quarter the interest is at 38.0. Based on that we can calculate that during remaining 53 days it will total up to 91.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201954
321
494.4% QoQ
143
-55.5% QoQ
188
31.5% QoQ
2020 196
263.0% YoY 4.3% QoQ
88
-72.6% YoY -55.1% QoQ
96
-32.9% YoY 9.1% QoQ
221
17.6% YoY 130.2% QoQ
2021 63
-67.9% YoY -71.5% QoQ
129
46.6% YoY 104.8% QoQ
238
147.9% YoY 84.5% QoQ
102
-53.8% YoY -57.1% QoQ
2022 142
125.4% YoY 39.2% QoQ
176
36.4% YoY 23.9% QoQ
192
-19.3% YoY 9.1% QoQ
154
51.0% YoY -19.8% QoQ
2023 96
-32.4% YoY -37.7% QoQ
120
-31.8% YoY 25.0% QoQ
41
-78.6% YoY -65.8% QoQ
138
-10.4% YoY 236.6% QoQ
2024 38
-60.4% YoY -72.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Surrozen search interestLast update: February 07 2024 21:32:18.
Correlation coefficient between keyword and revenue is 0.22
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 21:32:19.

The average 5 years interest of Surrozen was 11.29 per week.
The last year interest of Surrozen compared to the last 5 years has changed by -33.92%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -53.14%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Surrozen Surrozen stock to provide analysis

Correlation between past revenue and Surrozen Surrozen stock search interest

There is not enough data for Surrozen Surrozen stock to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Surrozen Surrozen stock to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Surrozen biotechnology to provide analysis

Correlation between past revenue and Surrozen biotechnology search interest

There is not enough data for Surrozen biotechnology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Surrozen biotechnology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 21:32:23.

After 38 days of this quarter the interest is at 176.0. Based on that we can calculate that during remaining 53 days it will total up to 421.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019306
391
27.8% QoQ
275
-29.7% QoQ
524
90.5% QoQ
2020 533
74.2% YoY 1.7% QoQ
381
-2.6% YoY -28.5% QoQ
289
5.1% YoY -24.1% QoQ
390
-25.6% YoY 34.9% QoQ
2021 384
-28.0% YoY -1.5% QoQ
281
-26.2% YoY -26.8% QoQ
317
9.7% YoY 12.8% QoQ
259
-33.6% YoY -18.3% QoQ
2022 515
34.1% YoY 98.8% QoQ
473
68.3% YoY -8.2% QoQ
367
15.8% YoY -22.4% QoQ
434
67.6% YoY 18.3% QoQ
2023 569
10.5% YoY 31.1% QoQ
471
-0.4% YoY -17.2% QoQ
308
-16.1% YoY -34.6% QoQ
507
16.8% YoY 64.6% QoQ
2024 176
-69.1% YoY -65.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Wnt pathway search interestLast update: February 07 2024 21:32:22.
Correlation coefficient between keyword and revenue is -0.21
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 21:32:24.

The average 5 years interest of Wnt pathway was 31.35 per week.
The last year interest of Wnt pathway compared to the last 5 years has changed by 17.42%.
The interest for Wnt pathway is trending.
The last year interest is comparable to 5 years ago. It has changed only by 12.12%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:23:57.

After 39 days of this quarter the interest is at 313.0. Based on that we can calculate that during remaining 52 days it will total up to 730.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019320
377
17.8% QoQ
473
25.5% QoQ
465
-1.7% QoQ
2020 503
57.2% YoY 8.2% QoQ
428
13.5% YoY -14.9% QoQ
529
11.8% YoY 23.6% QoQ
533
14.6% YoY 0.8% QoQ
2021 580
15.3% YoY 8.8% QoQ
418
-2.3% YoY -27.9% QoQ
481
-9.1% YoY 15.1% QoQ
482
-9.6% YoY 0.2% QoQ
2022 677
16.7% YoY 40.5% QoQ
500
19.6% YoY -26.1% QoQ
583
21.2% YoY 16.6% QoQ
644
33.6% YoY 10.5% QoQ
2023 677
0.0% YoY 5.1% QoQ
537
7.4% YoY -20.7% QoQ
636
9.1% YoY 18.4% QoQ
831
29.0% YoY 30.7% QoQ
2024 313
-53.8% YoY -62.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and tissue repair search interestLast update: February 07 2024 21:32:28.
Correlation coefficient between keyword and revenue is 0.5
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:23:59.

The average 5 years interest of tissue repair was 42.1 per week.
The last year interest of tissue repair compared to the last 5 years has changed by 22.42%.
The interest for tissue repair is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 46.71%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Wnt pathway drug candidates to provide analysis

Correlation between past revenue and Wnt pathway drug candidates search interest

There is not enough data for Wnt pathway drug candidates to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Wnt pathway drug candidates to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SZN-043 to provide analysis

Correlation between past revenue and SZN-043 search interest

There is not enough data for SZN-043 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SZN-043 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SZN-1326 to provide analysis

Correlation between past revenue and SZN-1326 search interest

There is not enough data for SZN-1326 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SZN-1326 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SZN-413 to provide analysis

Correlation between past revenue and SZN-413 search interest

There is not enough data for SZN-413 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SZN-413 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for SRZN
Earnings date: 2024-03-19 After close
Company name: Surrozen Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T20:05:00Z

GlobeNewswire
Surrozen to Present at Upcoming Healthcare Investor Conference

2026-05-07T11:09:07Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $44

2026-05-06T20:05:00Z

GlobeNewswire
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update

2026-04-28T20:05:00Z

GlobeNewswire
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-04-21T16:33:45Z

Analyst Upgrades
TD Cowen Initiates Coverage On Surrozen with Buy Rating

2026-03-24T11:03:12Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Surrozen, Raises Price Target to $36

2026-03-23T20:05:00Z

GlobeNewswire
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

2026-02-25T21:05:00Z

GlobeNewswire
Surrozen to Present at Upcoming Healthcare Investor Conference

2026-02-23T21:30:00Z

GlobeNewswire
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-02-19T13:38:37Z

Analyst Upgrades
Cantor Fitzgerald Initiates Coverage On Surrozen with Overweight Rating, Announces Price Target of $40

2026-02-05T21:05:00Z

GlobeNewswire
Surrozen to Present at Upcoming Healthcare Investor Conference

2025-11-25T21:05:00Z

GlobeNewswire
Surrozen to Present at Upcoming Healthcare Investor Conferences

2025-11-12T22:01:40Z

GlobeNewswire
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2025-11-07T21:05:00Z

GlobeNewswire
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update

2025-11-05T21:05:00Z

GlobeNewswire
Surrozen to Present at Upcoming Healthcare Investor Conference